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In previous communications from this laboratory (1, 2) it was demonstrated 
that  bone marrow cells of normal rabbits  are capable of undergoing blasto- 
genesis and mitosis upon incubation with a large number of antigens in vitro. 
Antibody formation by the bone marrow cells in vitro was detected by the 
fluorescent antibody technique (2). When a relatively large dose of an antigen 
was injected into a  rabbit and the bone marrow removed 24 hr later, the ca- 
pacity of these cells to respond  to the specific antigen in vitro was lost,  al- 
though the response to other non-cross-reactive antigens was intact.  The in- 
jection of a lesser amount of the antigen into the donor resulted in a lengthen- 
ing of the time required for the bone marrow to lose the capacity to respond 
to the specific antigen in vitro. Fractionation of normal bone marrow cells on a 
sucrose density gradient permitted the separation of a  fraction high in  con- 
centration  of lymphoid cells  and  a  fraction of bone marrow containing the 
majority of myeloid and erythroid precursors. The former was very reactive 
when exposed to antigens in vitro, whereas the latter reacted only weakly in 
response to  antigenic stimulation  in  vitro  (2,  3).  Since,  of all  the lymphoid 
tissues of the normal rabbit, only the bone marrow lymphoid cells demonstrated 
this capacity to react with antigens in vitro, it was concluded that the com- 
mitted immunocompetent cells originate in the bone marrow of the rabbit and 
that  they vacate  the  bone marrow  shortly after  their  interaction  with  the 
particular antigen  (2).  We have now confirmed and  extended these  original 
observations using a cell transfer system. 
It has been demonstrated, in the experiments presented below, that irradi- 
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ated  rabbits  injected with  bone marrow cells of normal  rabbits  are capable  of 
forming  antibodies  to  sheep  and  horse  red  blood  cells,  whereas  irradiated 
rabbits  injected  with  bone  marrow  cells  obtained  from  rabbits  injected  with 
sheep red blood cells 24 hr prior to transfer  of their cells are unable  to synthe- 
size  antibodies  to  sheep  red  cells  although  they  can  to  heterologous  (horse) 
red blood cells. Data  of preliminary  experiments  have already been presented 
(4). 
Methods and Materials 
Only outbred adult New Zealand white rabbits were used in these experiments. The antigens 
used were sheep red blood cells (S-RBC), sheep red cell stroma, horse red blood cells (H-RBC), 
and horse red cell stroma. The stroma were prepared by centrifugation of the red cells at 2000 
rpm for 10 min after lysis with distilled water. The sediment, consisting of the red cell stroma, 
was  suspended  in  a  volume of  Medium  199  (Microbiological Associates,  Bethesda,  Md.) 
equivalent to the original cell concentration. 
In the experiments reported upon below, a primed rabbit is considered to be one injected 
with the antigen 18-24 hr prior to sacrifice, when the bone marrow has lost its capacity to re- 
spond to the antigen in vitro (2) but long before antibody can be detected in the circulation. 
An immuni~.ed rabbit is defined as one possessing  circuiating immtmocompetent ceils or anti- 
body at the time of sacrifice,  usually 8-10 days after antigen administration. 
Normal, primed, or immune rabbits were sacrificed by the intravenous injection of Nembu- 
tal. The bone marrow from both the tibia and femur was removed and suspended in sterile 
normal rabbit serum (NRS) (Microbiological Associates)  in sterile plastic tubes (Falcon Plas- 
tics, Los Angeles, Calif.) and shaken vigorously for 1-2 rain to obtain a ceil suspension,  as has 
been previously described (1-3). The tubes were centrifuged at 600 rpm for 10 rain; the fatty 
upper layer was decanted and the cells resuspended in Medium 199. They were washed once 
more in Medium 199 and resuspended in Medium 199 containing 100 units peniciUin,  100 ~g 
streptomycin, and 15% NRS/ml (Med-PS-NRS) to a cell concentration of 10  a lymphoid cells/ 
ml. They were kept in a 37°C incubator until they were injected intravenously into rabbits 
which had just been subjected to 800 R total body incidence dose irradiation using a 2000 curie 
cobalt-d0 source with a skin source distance of 100-125  cm and an output of 60 R/rain. The 
recipient irradiated rabbits were also injected with 109 S-RBC and were maintained in a regu- 
lar animal house. The rabbits were sacrificed by the intravenous administration of Nembutal, 
and the spleens removed and passed through wire meshes into Med-PS-NRS to provide cell 
suspensions  (2). The latter were analyzed for plaque-forming ability to S-RBC and/or H-RBC 
using  the hemolytic plaque  technique of Jerue  and  Nordin  (5)  with slight modifications. 
Agarose was used in place of agar as described in the original procedure. The spleen cells (0.1 
ml), washed sheep red cells (0.1 ml of a 12% suspension),  and the agarose (1 ml of a 0.5% solu- 
tion) were mixed throughly in a 46°C water bath and layered into the Petri dishes which were 
then allowed to stand at 37°C for 2 hr. 1 ml of commercial guinea pig serum (Hyland Labora- 
tories, Los Angeles,  Calif.), diluted 10-fold, was then added. The plates were left at 37"C for 
another hour and the plaques were counted with the aid of a magnifying lens. The resuits are 
expressed as the number of plaque-forming cells per 10  s splenic lymphoid  cells plated.  The 
variation in the number of plaques observed in duplicate assays was consistently less  than 
4-10% from the mean. 
Controis consisted of  (a)  normal nonirradiated rabbits  injected with S-RBC or  H-RBC 
(109 RBC); (b) normal, nonirr~liated rabbits not injected with S-RBC or H-RBC;  and  (c) 
irradiated rabbits injected with S-RBC or H-RBC  (109 RBC). The spleen cells of all these 
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Other rabbits were injected with S-RBC (109 ceils) and sacrificed 3, 5, 6, 7, 8, 10, and 12 
days Inter. Bone marrow, spleen, lymph node (mesenteric and popliteal), thymus, appendix, 
and sacculus rotundus lymphocytes were prepared as cell suspensions in Med-PS-NRS (2) and 
tested for plaque-forming ability to S-RBC and H-RBC. The results are expressed as the num- 
ber of plaque-forming cells per l0  s lymphoid ceils tested. 
Normal and primed spleen cells were also tested for their ability to undergo blastogenesis 
and mitods in vitro in the presence of the specific nntigen(s). The cell culture technique and 
method for determining the extent of radioactive SH-thymidine incorporation utilized in these 
experiments have been described in detail previously (2). Briefly, the cells were suspended in n 
concentration of 10S/ml in Med-PS-NRS and 4 ml aliquots of the cell suspension were trans- 
ferred into sterile Falcon plastic tubes. Where stated, antigen was added at the beginning of 
culture. The tubes were Sealed and placed in a 37°C incubator for 3 days. Tritiated thymidine 
(2 t~c, specific activity 1 c/m~¢) was added to the tubes 18-24 hr prior to the termination of 
culture, at which point the tubes were centrifuged at 2000 rpm for 10 rain, washed twice with 
5% trichioroacetic add, and digested overnight with Hyamine (Packard Instruments, Downers 
Grove, Ill.). The cell digests were then transferred to scintillation counting vials with ethanol; 
15 ml of scintillation solution was added to each vial, and the radioactive content of each vial 
was determined with n Packard Model 4000 liquid scintillation counter. 
Antlsera to S-RBC and H-RBC were prepared in rabbits by the intravenous administration 
of 1 ml of a 10% suspension of the red cells at weekly intervals for 3 wk. The rabbits were bled 
7-10 days after the last injection, and the sera obtained after centrifugation of the clotted 
bloods were stored at --10°C until used. 
The data presented in each table are representative of a  typical experiment. Each value 
presented in the tables below represents the mean of duplicate or triplicate determinations ob- 
tained with the tissues of two or three different rabbits. Each experiment was repeated in its 
entirety in an identical fashion at least three times except where otherwise stated. In view of 
the consistent nature of the results obtained, not a  single experiment of the more than 50 
comprising this study was deleted. It must also be emphasized that the variations in the num- 
ber of plaques observed with the tissues of different rabbits, treated in an identical fashion 
and under the same experimental conditions, were found not to exceed ±  10% of the mean 
value. Therefore,  for the sake of simplicity of presentation, the ranges in the numbers of 
plaques obtained have been omitted from the tables. 
EXPERIMENTAL  PROCEDURES  AND  RESULTS 
A.  Plaque-Forming  Ability  of the  Different  Rabbit  Lymphoid  Tissues  and 
the Optimal Conditions for the Induction of Primed Bone Marrow In  Vivo and 
of Hemolytic  Plaques  In  Vitro  (Experiments I-IV).--This  initial sequence of 
experiments was  carried out to establish  base line values for the various pa- 
rameters utilized in the experimental protocols outlined below.  They consti- 
tute the framework upon which the interpretations of the results of the sub- 
sequent experiments are based. 
Rabbits were injected intravenously with 106, or l0  g, or 10  s or 109 S-RBC and sacrificed 7 
days later. Cell suspensions of the various lymphoid organs were prepared and were analyzed 
for plaque-forming capacity of S-RBC plated in constant or varying concentrations of lym- 
phoid cells.  Bone marrow suspensions were also prepared from rabbits injected with varying 
numbers of S-RBC 24 hr previously and injected into irradiated recipients. The latter were 
sacrificed 7 days later, and the plaque-forming capacity of the spleen cells was determined. 76O  CELLS  INVOLVED  IN  IMMUNE  RESPONSE.  VI 
As can be seen in Table I, only the spleen ceils d  immunized rabbits were 
capable of forming hemolytic plaques  with  S-RBC.  The maximum immune 
reactivity of the spleen was attained between days 6 and 8 after immnnlzation. 
Very few plaques could be detected be/ore day 3 and after day 12. 
As can be seen in Table II, the administration of 10  ~ S-RBC resulted in the 
TABLE I 
Plaque-Forming Capacity of Different Lympkoid  Organs of Rabbits Immunized  with Sheep 
Red Blood Cells (109  Cells) 
Cells of lymphoid organ plated 
Time after 
Kntlgen 
administration  Spleen  Thymus  Bone marrow  Lymph node  Sacculus  Appendix 
rotundus 
No. of ptaques/lO 6 lymphoid  cdls  darts 
3 
5 
6 
7 
8 
10 
12 
5 
15 
54 
73 
66 
31 
8 
<1 
<1 
2 
<1 
<1 
<71 
<71 
<1 
<1 
<1 
2 
1 
2 
<71 
1 
2 
2 
7 
<1 
<1 
1 
1 
1 
2 
1 
1 
<71 
<I 
TABLE II 
Plaque-Forming Capacity of Splenic  Lymphoid  Cells of Rabbits Immunized  with  Varying 
Doses of Sheep Red Cells 7 Days Prior to Sacrif~e 
No. of sheep red cells administered 
10  9 
10  8 
10  7 
i0  8 
No. of plaques/10  e spleen lymphoid 
cells plated (day 7) 
71 
47 
5 
1 
production of the maximum number of plaques by the spleen ceils on the 7th 
postimmunization day. The maximum number of plaques was observed when 
2  X  106 to 8  X  10 e splenic cells were plated. Greater numbers of splenic cells 
(24  ×  10 e or 32  X  108) tended to exert an inhibitory effect on the system re- 
suiting  in  an  almost  complete  inhibition  of  plaque  formation  (Table  III). 
As can be seen in Table IV, bone marrow cells of donor rabbits given 108, 
109, or  10  x°  S-RBC  were  incapable  of  transferring  plaque-forming  capacity 
with  respect  to S-RBC  to the  irradiated,  recipient rabbits,  whereas  this  ac- 
tivity was possessed by bone marrow ceils obtained from rabbits injected with 
106 or 10  ~ S-RBC 18-24 hr prior to sacrifice. 
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number of hemolytic plaques would be obtained by plating 2  X  106-8  X  106 
spleen cells of rabbits given 10. S-RBC 6-8 days prior to sacrifice. Furthermore, 
the bone marrow ceils obtained from a  rabbit injected intravenously with  10' 
TABLE III 
Rdationship between Number of Splenic Lympturid Cells Plated and Number of Plagues Obtained 
from Spleen of Same Donor 
No. of splenic  lymphoid  ceils plated (X I0  e)  No. of plaques/10  e splenic  lymphoid  cells" 
32 
24 
16 
8 
6 
4 
2 
1 
7 
28 
62 
67 
69 
69 
* Spleen ceUs obtained from  rabbit immunized 7  days  earlier with  109 S-RBC  intra- 
venously. 
TABLE IV 
Plague-Forming Capacity of Splenic Lymphoid Cells of Irradiated Rabbits Wkick Had Been 
Injected with AUogenoic Bone Marrow  from Donors Primed with Different 
Doses of S-RBC 
No. of S-RBC  injected into donors* 
1010 
109 
108 
107 
10  e 
No. of plaques/10  e splenic lymphoid  cells  of 
recipient  ~bbits$ (d~y 7) 
4 
8 
7 
23 
35 
* Donors were given S-RBC intravenously 24 hr prior to sacrifice. 
Rabbits were subjected to 800  R  total body irradiation followed  by the intravenous 
injection of 5 X  108 bone marrow cells and 1 X  109 S-RBC. 
S-RBC 24 hr prior to sacrifice had lost the capacity to confer immunocompe- 
tence to S-RBC when transferred to an irradiated recipient. 
B.  The  Transfer  of  Plaque-Forming  Capacity  with  Primed  Bone  Marrow 
Cells (Experiments V-VII).-- 
Rabbits were injected with 109 S-RBC intravenously and sacrificed at varying intervals of 
time. Bone marrow cell suspensions were prepared in the manner described above and in- 
jected intravenously into irradiated recipient rabbits together with 109 S-RBC. The latter 
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As can  be seen in Table V,  the bone marrow  cells of rabbits primed with 
S-RBC  24 hr prior to sacrifice were unable to confer plaque-forming capacity 
to spleens of recipient irradiated rabbits.  On  the  other hand,  the  spleens of 
irradiated recipients of normal,  allogeneic rabbit bone  marrow  displayed the 
TABLE V 
Plaque-Forming Capacity of Splenic Lymphoid Cells of Irradiated Recipients 7 Days  after 
Administration of Primed (S-RBC) or Normal Allogeneic Rabbit Bone Marrow Cells 
Type of  bone  marrow transferred 
(0.5 X  log lymphoid  cells) 
Primed: l  days 
Normal 
None 
Normal 
No. of sheep red cells injected 
into irradiated recipient 
i0  9 
tO  9 
tO  9 
None 
No. of plaques/los splenic 
lymphoidcells or irradiated 
recipients*  (day 7) 
4 
72 
5 
5 
* Recipients were  subjected to 800 R  total body irradiation prior to administration of 
sheep RBC or bone marrow cells. 
$ Bone marrow cells obtained from rabbit given 1 X  109  sheep red cells, intravenously 
24 hr previously. 
TABLE VI 
Rdation  between the Number of Normal or Primed Bone Marrow Calls Injected and  Their 
Capacity to Confer Plaque-Forming Ability to the Spleens of Irradiated Recipient 
Rabbits 7 Days Later 
No. of bone marrow cells transferred 
to irradiated recipient 
9X  10  8 
5 X  108 
2X10 s 
t  X  10  8 
0.5X  108 
No. of plaques/10  s  splenic  lymphoid cells  of  recipients*  receiving 
Normal bone marrow 
72 
71 
30 
12 
12 
Primed bonemarrow 
11 
N.D.:~ 
N.D. 
N.D. 
N.D. 
* Recipients were subjected to 800 R followed by the injection of bone marrow cells and 
1 X  109 sheep red cells given intravenously. 
N.D., not done. 
same number  of plaques as were obtained with spleens of normal rabbits im- 
mtmized  with  S-RBC  and  tested  7  days  later  (compare  Tables  I  and  V). 
Irradiated recipients given only S-RBC  or normal  bone  marrow  did not  ex- 
hibit plaque-forming capacity (Table V). 
As can be seen in Table VI, as few as 2 X  10  8 normal allogeneic bone marrow 
cells  were  capable  of  transferring  plaque-forming  capacity  to  irradiated  re- 
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incapable d  inducing responsiveness in spleens d  irradiated recipients to any 
degree above background. 
Table VII summarizes  the results obtained with  bone  marrow  cells trans- 
ferred at different intervals of time after the administration of the antigen to 
the donor rabbit. The maximum loss of capacity of the bone marrow to trans- 
fer plaque-forming ability is 24-48 hr after immunization with S-RBC. How- 
ever, most of the activity appears to be lost as early as 8 hr after the S-RBC 
injection and  does not  reappear until 3-5  days after S-RBC  administration. 
TABLE VII 
Relation between Time of Antigen Administration (Priming) and the Capacity of Primed Bone 
Marrow Cells to Confer Plaque-Forming Ability to Spleens of Irradiated Recipient 
Rabbits 7 Days Later 
Interval between antigen administration* into donor  No. of plaques/IO s splenic  lymphoid cells of 
and transfer of bone marrow cells to irradiated  irradiated recipient (day 7)5 
recipient 
2hr 
4  ~ 
8  ~ 
I day 
2  ~ 
3  ~c 
8  c~ 
10  " 
69§ 
71 
12 
4 
5 
11 
92 
81 
84 
* 1 ×  109 sheep red cells given intravenously. 
:~ Recipients were subjected to 800 R  total body irradiation followed by the injection of 
0.5 ×  10  ° bone marrow cells and 1 X  109 sheep red cells. 
§ Control values axe 72 plaques for irradiated recipients given normal bone marrow  and 
sheep RBC and 5 plaques for irradiated recipients given sheep RBC only. 
The  reactivity d  the  bone marrow  transferrred  after day 5  after immuniza- 
tion generally exceeded that  of normal  bone marrow allografts. 
C.  The Specific Loss of Antibody-Forming Capacity to Skeep Red Blood Cells 
by Primed Bone Marrow Cells  (Experiments  VIII-X).-- 
Normal rabbits were injected intravenously with 109 S-RBC and sacrificed 24 lax later. The 
bone marrow cell suspensions prepared from these rabbits were injected into irradiated reci- 
pient rabbits along with 109 S-RBC. They were then bled at intervals of time, and the serum 
samples were  analyzed for their anti-S-RBC agglutinin fiters by the conventional hemag- 
glutination test. Some of the rabbits were sacrificed at day 7, and the spleen cells were tested 
for their capacity to undergo blastogenesis and mitosis in the presence of the antigen in vitro. 
Several bone marrow donor rabbits were passively  immunized with high-titered rabbit anti- 
S-RBC antiserum 24 hr prior to sacrifice. The anti-S-RBC titers in these donors was 1:320 at 764  CELLS  INVOLVED IN  IMMUNE  RESPONSE.  VI 
time of sacrifice.  Recipients of these bone marrow specimens were injected with 10  9 S-RBC 
and were sacrificed 7 days later, and their spleens were analyzed for plaxtue-forming capacity. 
As can be  seen in Table VIII,  spleen cells  of rabbits  which had received 
normal allogeneic bone marrow cells  were stimulated to undergo mitosis and 
blastogenesis  and  to  incorporate  tritiated  thymidine  when  incubated  with 
TABLE  VIII 
Antigen-Induced In Vitro Incorporation of Tritiated Thymidine by Spleen Cdls of Irradio2ed 
Rabbits Given Primed (S-RBC  or Normal Allogeneic Rabbit Bone Marrow Cdls 
Incorporation of trltiated thymidine  by spleen  cells of 
irradiated  rectple" " nts*  of  Material added to cell cultures 
(4 X  to  4 cells) 
Normal bone marrow cells  Primed bone  marrow cells:~ 
Nil 
PHA 
S-RBC stroma 
Specific incorporation§ 
c~ 
51 
793 
3149 
61 
96 
1119 
89 
0.9 
* Recipients were subjected to 800 R total body irradiation and then injected with 0.5  X 
109 bone marrow cells and 1 X  109 S-RBC. They were sacrificed 7 days later. 
Donor was primed by the intravenous injection of I X  109 S-RBC I day prior to transfer. 
§ Ratio of *H uptake by spleen cells in the presence of S-RBC stroma to that incorporated 
in the absence of S-RBC stroma. 
TABLE  IX 
Humoral Immune Response to Sheep Red Blood Cdls (S-RBC) of Irradiated Recipients Injeaod 
with Primed (S-RBCO or Normal Allogeneic Bone Marrow Cells 
Recipient*  bled at day 
0 
7 
11 
14 
21 
28 
35 
42 
49 
56 
Hemagglutination titers of recipients  given 
Normal bone marrow 
0 
160 
64O 
1280 
2560 
640 
160 
160 
80 
0 
Primed bone  marrow 
0 
0 
0 
20 
40 
0 
0 
0 
0 
0 
* Recipients were subjected to 800 R  total body irradiation followed by the injection of 
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S-RBC stroma in vitro, with a specific incorporation index of 61. On the other 
hand, spleen cells of rabbits which had received bone marrow primed to S-RBC' 
were incapable of responding in the presence of S-RBC stroma  (specific  in- 
corporation index of 0.9), although in this particular instance they were more 
stimulated by phytohemagglutinin (PHA)  than were the spleen cells  of the. 
rabbits  which had received the normal bone marrow cells,  thus attesting to 
TABLE  X 
Plaque-Forming Capacity of Splenic Lymphoid Cells of Irradiated Recipients Which Had 
Received Bone  Marrow  Cells Obtained from  Donor Rabbits Passi~dy  Immunized 
with Antlserum to Sheep Red Blood Cells 
Treatment of bone marrow donor 
Rabbit anti-Sheep-RBC* 
None 
AntI-S-KBC titer of bone marrow donor at 
intervals of time after injection of antiserum 
1 hr 
320 
4hr 
320 
24 hr 
160 
No. of plaques/10  ~ 
splenic lymphoid 
cells of recipient 
rabbits 
64 
67 
* Rabbit was given 5  ml of antiserum (titer 32,000)  intravenously at time 0  and sacri- 
riced  24 hr later. 
TABLE  XI 
Cross-Reactivity between Horse and Sheep Red Blood Cells--In Vivo Response in Normal Rabbits 
Cells used for 
immunization 
(l  ×  l~) 
S-RBC 
H-RBC 
Hemagglutinstlon titer on day 
AntI-H-RB  C  Anti- S-RBC 
10  640 
1,280  0 
14 
Anti-H-RBC  Anti-S-RBC 
40  25,600 
40,000  80 
No. of plaques/10  s splenic 
lymphoid cells on day 7 
incubated with 
H-RBC  S-RBC 
7  71 
97  5 
the viability of the cells in vitro (Table VIII). Further evidence supporting the 
inability of primed bone marrow to  transfer specific  antibody formation to 
irradiated recipients is presented in Table IX. The recipients of normal bone 
marrow were  able  to  respond with an  apparently normal humoral immune 
response to S-RBC, whereas sera of recipients of S-RBC-primed bone marrow 
either possessed no circulating anti-S-RBC antibodies or, at most, exceedingly 
low fiters of antibody which were delayed in onset. 
Passive  immunization of  normal  donor  rabbits  with  homologous anti-S- 
RBC  antiserum did not  affect the  transfer of {mmunocompetence by  their 
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D.  The Specificity  of the Immune Response  to S-RBC and H-RBC of Spleen 
Cells  of Rabbits  Injected  with Bone Marrow Cells from  Rabbits  Primed  with 
Sheep and~or Horse Red Blood Cells (Experiments  XI-XIV).-- 
Normal rabbits were injected intravenously with either S-RBC and/or  H-RBC  (10  9 cells) 
and bled at intervals of time. The serum samples were tested for their agglutinin titers to these 
two red cell preparations. Several rabbits were sacrificed on day 7, and their spleen cells were 
examined for their plaque-forming ability and for their capacity to incorporate tritiated thy- 
midine in the presence of the specific antigen(s) in vitro. 
As can be seen in Table XI, rabbits immunized with S-RBC formed anti- 
bodies  essentially  only  to  S-RBC,  while  rabbits  immunized  with  H-RBC 
TABLE  XII 
Cross-Reactivity between Horse and  Sheep Red  Blood Cells--In  Vitro Response of Immune 
Rabbit Splenic Calls 
Cells used for immunization 
Specific incorporation* of radioactive thymidine by immune 
spleen cells~ in presence of 
H-RBC stroma  S-RBC stroma 
S-RBC  1.2  11.0 
H-RBC  13.0  0.8 
* Ratio of radioactive thymidine uptake by spleen ceils in presence of antigen to that 
taken up in the absence of the antigen. 
~: Normal rabbits were given the red cells intravenously on day 0 and sacrificed  on day 7. 
Spleen cells (4 X 10  °) were incubated in vitro with either type of red cell for 3 days. 
formed  antibodies  almost  entirely directed  to H-RBC.  The  plaque4orming 
capacity of the spleen cells of rabbits immunized with S-RBC produced plaques 
to S-RBC only, while spleen cells of rabbits immunlzed with H-RBC produced 
plaques directed to H-RBC only (Table XI). Similarly, spleen cells of rabbits 
immunized  with  S-RBC  incorporated  radioactive  thymidine  only when  in- 
cubated with S-RBC stroma in vitro, whereas spleen cells of rabbits immu- 
nized  with  H-RBC  incorporated  tritiated  thymidlne  only  when  incubated 
with H-RBC stroma (Table XII). 
However, spleen cells of irradiated recipient rabbits injected with bone mar- 
row cells of donors primed with S-RBC or H-RBC and immunized with both 
types of red cells produced plaques with respect to the heterologous antigen 
only, H-RBC or S-RBC, respectively (Table XIII). Spleen cells of irradiated 
rabbits which had received bone marrow from donors primed with both S-RBC 
and H-RBC were unable to form plaques to either of the red cell preparations. 
These data  were substantiated  by in vitro experiments with  spleen cells  of 
irradiated recipients. Spleen cells of irradiated rabbits which had received bone 
marrow primed with either S-RBC or H-RBC were capable of incorporating 
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TABLE XIII 
Specificity of Humoral Immune Response and Plaque-Forming Capacity  to Sheep and Horse 
Red Blood Cells of Recipients Injected with Primed  (S-RBC and~or H-RBC) 
Allo  ene~ Bone Marrow Cells 
Bone marrow donor primed with 
S-RBC 
H-RBC 
S-RBC and H-RBC 
Not primed 
Hemsgglutination titer of 
redpm" nt* serum at time 
of sacrifice 
H-RBC  S-RBC 
20  0 
0  4O 
0  0 
8O  40 
No. of plaques/lO  e of recipients* 
splenic lymphoid ceils incubated 
with 
H-RBC  S-RBC 
30  4 
5  61 
3  4 
22  54 
* Recipients were subjected to 800 R  total body irradiation followed by the  injection of 
0.5  X  10  ° bone marrow cells from the specific donor and  1 X  10  ° S-RBC and H-RBC. All 
the rabbits were sacrificed on day 7. 
TABLE XIV 
Specificity of In Vitro Response to Sheep and Horse Red Blood Cells of Splen~ Lymphoid  Cells 
of Irradiated Recipients Injected wiCk  Primed (S-RBC or H-RBC) Allogeneic 
Bone Marrow 7 Days Previously 
Bone marrow donor primed with 
S-RBC 
H-RBC 
S-RBC and H-RBC 
Not primed 
3pecific incorporation* of trltiated ~y~'.dine by recipient~ 
splenic lymphoid cells incubated m the presence of 
H-RBC stroma  S-RBC stroma 
5.6 
1.2 
1.2 
4.8 
0.8 
3.7 
0.6 
3.7 
* Ratio of radioactive thymidine uptake by the spleen cells in the presence of the antigen 
to that taken up in the absence of the antigen. 
~: Recipients were subjected to 800 R  total body irradiation followed by the injection of 
0.5 X  109 bone marrow cells from the specific donor and  1 X  109 S-RBC and H-RBC. All 
rabbits were sacrificed on day 7. Spleen cells (4 X  106) were incubated in vitro with either 
type of red cell stroma for 3 days. Radioactive thymidine was added to cultures on day 2. 
spleen cells of irradiated rabbits which had been injected with bone marrow of 
rabbits primed with both S-RBC  and H-RBC  were incapable of incorporating 
tritiated thymidine when incubated with either of the two red cell preparations 
in vitro (Table XIV). 
DISCUSSION 
The  experimental  protocols  carried  out in  the present  communication  were 
designed wholly on the basis  of the results presented  previously by this labora- 
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of  normal  rabbits  are  capable  of  undergoing  blastogenesis  and  mitosis,  of 
incorporating tritiated  thymidine, and  of synthesizing antibody in  response 
to  the  stimulus  provided  by  a  large  number  of antigenic  materials  (1,  2). 
(b)  The bone marrow cells  of immunized rabbits lose this in vitro reactivity 
when exposed to the specific immunizing antigen, but are as reactive as normal 
bone  marrow  cells  to  other,  non-cross-reacting antigens  (1,  2).  (c)  This  in 
vitro reactivity of the bone marrow cells  to an antigen was lost very shortly 
after the intravenous administration of the antigen, the eclipse or latent period 
not  exceeding 8-24  hr  when a  relatively large  quantity of the  antigen was 
administered (i.e., 25 mg human serum albumin [HSA],  10 nag keyhole limpet 
hemocyanin [KLH]). However, it took as long as 5-10 days for the bone marrow 
cells to lose their reactivity to the antigen if it had been injected inouly  threshold 
amounts (i.e.,  1 nag HSA)  (2).  (d)  The lymphoid cells  of the bone marrow, 
rather  than  other myeloid or erythroid elements of the  bone marrow,  were 
implicated as the cells  reactive to the antigen stimulus in vitro (3);  and  (e) 
the antigen-reactive cell probably migrates out of the bone marrow after con- 
tact with the antigen in vivo (4). 
Using three criteria--the hemolysis in agar (plaque) technique, the humoral 
immune response,  and the in vitro blastogenic and mitotic response  accom- 
partied by tritiated thymidine incorporation in response to antigenic stimula- 
tion-it was unequivocally demonstrated that primed rabbit bone marrow is 
deficient in cells capable either of initiating or mediating the immune response 
to the specific antigen in an irradiated recipient. This conclusion is based on the 
results of approximately 50 experiments, all of which, without exception, sup- 
port this interpretation. In each case, the bone marrow of rabbits injected with 
sheep red blood cells  18-24  hr prior  to the  transfer of their bone marrow to 
irradiated recipients failed to confer plaque-forming capacity to sheep red cells 
in the recipients, although the response to horse red cells, a non-cross-reacting 
antigen,  was  intact.  The  specificity of  this  loss  in  immunocompetence  was 
corroborated  by the failure of such recipient rabbits  to form humoral anti- 
bodies to sheep red cells after antigenic stimulation and by the inability of the 
recipient spleen cells to undergo blastogenesis and mitosis when incubated with 
the specific antigen in vitro. This deletion from the bone marrow of cells  ca- 
pable of reacting with sheep red cells was maximum 8-48  hr after the intra- 
venous injection of the red cells  (Table VII). Thus, one may conclude that a 
minimum of 8 hr was required for all the antigen-reactive cells directed to sheep 
red ceils to interact with the antigen and to vacate the bone marrow (recruit- 
ment time). 
Using an entirely different system in the rat, Ford (6)  arrived at a  similar 
conclusion. Irradiated rats were injected with syngeneic thoracic duct lympho- 
cytes either simultaneously with, or at varying times after,  the  injection of 
sheep red cells. The optimal hemolysin response was obtained in the rats given 
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restoration was 12 hr or more, the latent period of the hemolysin response after 
the time of administration of the sheep red cells was prolonged, and the entire 
hemolysin response was markedly diminished. These results implied that re- 
cruitment of antigen-reactive cells in the rat occurs only over 1 to 2 days after 
the injection of the sheep red ceils  (6), which is a time interval similar to the 
one found in the rabbit in the present investigation. 
It was demonstrated that a definite relationship exists between the number 
of sheep red cells used for priming the donor and the degree of loss of capacity 
by  the  bone marrow  to  transfer immunocompetence to  the  specific  antigen 
(Table IV). These results are essentially similar to those presented previously 
for various protein antigens (2)  and can be  explained on the basis  of more 
efficient and/or more rapid depletion from the bone marrow of the specific, 
precommitted cells as the number of sheep red cells injected is increased. 
It was  observed that  the loss  of capacity to  transfer immunocompetence 
to sheep red blood cells was most conspicuous 1-2 days after the injection of 
this antigen into the prospective bone marrow donor. However, this ability of 
the bone marrow to transfer specific immunocompetence reappeared by day 4 
after immunization of the donor  (Table  VII)  and was accompanied by the 
demonstration of similar activity by other lymphoid organs, such as the spleen, 
lymph node, and appendix.  1 This finding probably reflects the appearance of a 
circulating pool of maturing or mature immunocompetent cells, which should 
now probably be classified as antibody-forming cells. 
Passive  immunization of  the  bone  marrow  donor  with  high-titered  anti- 
serum to sheep red cells did not diminish the capacity of the donor bone marrow 
to transfer immunocompetence to sheep red cells (Table X). The data do not 
conflict with those of Wigzell (7), Dixon et al.  (8), Finkelstein and Uhr  (9), 
Uhr and Moiler (10),  and Henry and Jerne (11),  who showed that passively 
administered antibodies,  especially 7S  antibodies  (11),  can inhibit antibody 
synthesis within the same animal after an antigenic stimulus. In our experi- 
ments, only the bone marrow recipients received the antigenic stimulus. 
These data, taken as a  whole, strongly imply that the antigen-reactive ceil 
in the rabbit originates in the bone marrow and that it migrates out of the mar- 
row as soon as it interacts with the antigen. Once the antigen-reactive cells 
have vacated the bone marrow after interaction with the antigen, the bone 
marrow becomes unreactive or tolerant to this antigen and becomes deficient 
of the precursors of the antigen-reactive cells directed to the particular antigen. 
This loss is apparently permanent (2) and therefore the immunological memory 
which persists in the animal subsequent to the initial immune response must 
be a  property of the cells residing in the peripheral lymphoid tissues, mainly 
the spleen and lymph nodes (2). 
The results suggest that the bone marrow contains the different clones of 
1  Richter, M., and N. I. Abdou. Unpublished observations. 770  CELLS INVOLVED IN IM~fUNE RESPONSE. VI 
lymphoid cells  which  give  rise  to  the  potentially immunocompetent cells, 
which either transform directly into or give rise, by mitosis and differentiation, 
to the precommitted antigen-reactive cells. The concept of precommitment of 
the cell to intereact with a particular antigen encountered at some future time 
(2,  11, 12)  accepts the tacit assumption that this cell must possess antibody- 
like receptor groups on its surface, as has been suggested by a number of in- 
vestigators (11,  13, 14), capable of interacting with the antigen and thus initi- 
ating the inter-  and/or intracellular chain of events which culminate in  the 
humoral immune response.  This  interpretation  of our  data necessarily sup- 
ports the side chain concept of Ehrlich presented almost a  century ago (15) 
and also reaffirms the clonal selection theory of Burnet concerning the bone 
marrow  (16).  Other  investigators  (17-20)  have  also  presented  evidence  in 
favor of the clonal selection theory of antibody formation, although the organ 
site of origin of these cells has not previously been seriously entertained. 
Trentin et al. (21)  have presented evidence which conflicts with the clonal 
selection concept. Irradiated mice which had received a  minimal number of 
discrete  colonies of splenic  cells  were  able  to  respond  imrnunologically to  a 
number of antigens to a  degree similar to that observed in nonclonal control 
mice. If the immunocompetent cells were indeed precommitted to the antigen 
and  type of immune response,  one would not have  anticipated normal im- 
munologic responsiveness to a number of unrelated antigens in an animal which 
had been repopulated after heavy irradiation with only a  few stem cells and 
their progeny obtained from an  adult donor. However, this  interpretation is 
based on the supposition that all recipient stem cells  were destroyed by the 
irradiation,  which is  hardly likely since  they were subjected to only 850  R 
irradiation. 
The role of the bone marrow in the initiation and maintenance of the im- 
mune response, and as a prime, if not only, source of immunologically-compe- 
tent cells, has been discussed at length in a previous report (2). Therefore, only 
select references will be referred to here. Tyan and Cole (22)  have presented 
evidence that the bone marrow serves the adult mouse as the sole  source of 
potential immunologically competent cells. They have shown that deaths from 
graft-versus-host disease occurred among host mice only when  they had  re- 
ceived spleen cells from mice which had been injected with adult bone marrow. 
Feldman and  Globerson (23)  have reported that the immunological activity 
manifested by thymectomized mice,  which had been lethally irradiated but 
protected with bone marrow cells and restored to immunological competence 
with an allogeneic thymic graft, is due to the donor marrow cells rather than to 
cells from the thymic graft. Results of a similar nature were obtained by Glober- 
son (24) and Globerson and Auerbach (25) with a wholly in vitro system.The abil- 
ity of the adult mouse spleen  to evoke a  graft-versus-host reaction in vitro 
was lost after sublethal irradiation but could be regenerated when such spleens NABIH  I.  ABDOU  AND  MAXWELL  RICHTER  771 
were grown in the presence of thymus tissue. However, after lethal doses of 
irradiation,  reactivation  of  immune  competence  did  not  occur  unless  both 
thymus and bone marrow cells were present. They concluded that the bone 
marrow appeared  to supply the immunocompetent cells.  Goldschneider and 
McGregor (26) and McGregor (27) have shown that rat bone marrow can act 
as a  source or reservoir of precursor cells which can give rise to the immuno- 
ogically competent lymphocyte. They demonstrated that circulating lympho- 
lytes  capable  of  initiating lethal  graft-versus-host reactions  in  the  rat  can 
develop from myeloid precursors.  The  most recent  work  of Miller  and his 
colleagues (28-31)  lends further support to the mounting evidence in favor of 
the bone marrow as the origin of the antibody-forming cell.  They concluded 
from  their  studies  that  the  mouse  marrow  cell  suspensions  lack  adequate 
numbers of immunologically competent cells but contain precursor cells which 
mature into antibody-forming cells under the influence of the thymus. In this 
context, our results, which are  the only ones obtained in the rabbit,  concur 
with results obtained by all other investigators who have used mice and rats. 
However, our results concerning the origin of the antigen-reactive cell do not 
agree with these of Miller et al (28-31)  who demonstrated a thymic origin for 
the antigen-reactive cell in the mouse. Whether the dichotomy of these results 
implies an altered function for some of the lymphoid organs in the ontogeny 
and  phylogeny  of  the  immune  response  in  different  species  of  animals, 
or whether we are dealing with bone-marrow derived cells  in the thymus of 
the mouse or thymic-derived cells in the bone marrow of the rabbit, is unclear. 
This remains a problem for future experiments to elucidate. 
Two questions stand out in light of the results reported in this and in the 
previous communications: (a) Do the antigen-reactive cells actually leave the 
bone marrow or do they become inactivated or "tolerant" to the antigen and 
therefore assume an incidental role in the immune response? (b) Do the bone 
marrow-derived antigen-reactive cells  identified by the induction of the hu- 
moral immune response also mediate the cellular or delayed immune reaction? 
Evidence  has  previously  been  presented  demonstrating  the  capacity  of 
normal rabbit bone marrow lymphoid cells to form antibody in vitro 5 days 
after their incubation with antigen, as detected by the fluorescent antibody 
technique (2).  Other data have suggested that these antibodies are of a cyto- 
philic type since they were not released from the cells into the supernatants of 
the  cell  cultures but were rather  retained by the  cells  after four successive 
washings.  1 These  findings  suggest  that  rabbit  bone marrow lymphoid cells 
are  involved in  the  induction of  the  cell-mediated immune reactions.  This 
interpretation of our data is supported by the recent findings of Lubaroff and 
Waksman (32, 33),  who observed that the cell(s)  mediating the "delayed" or 
cellular immune reaction in the rat are derived from the bone marrow. It is 
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cell,  which  may have arisen independently from the antigen-reactive cell in 
the bone marrow or may be a transformed product of the antigen-reactive cell, 
is capable of undergoing maturation in various lymphoid organs of the irradiated 
recipient and to convert to an antibody-forming cell capable of synthesizing 
humoral  antibodies.  Certainly, it  would  appear  that  in  the  mouse  and  rat, 
the cells mediating the humoral (27-31) and cellular (32, 33) immune reactions 
are both derived from the bone marrow. Experiments are presently in progress 
to elucidate the target organ(s) for the antigen-reactive cells which leave the 
bone marrow in the rabbit. 
5~ARY 
Irradiated  rabbits  given  allogeneic bone  marrow  cells  from normal  adult 
donors responded to an injection of sheep red blood cells by forming circulating 
antibodies. Their spleen cells were also capable of forming many plaques using 
the hemolysis in gel technique, and were also capable of undergoing blastogen- 
esis  and  mitosis  and  of  incorporating  tritiated  thymidine  upon  exposure 
to  the  specific  antigen  in  vitro.  However,  irradiated  rabbits  injected  with 
allogeneic bone marrow obtained from rabbits injected with sheep red blood 
cells 24 hr prior to sacrifice (primed donors) were incapable of mounting an 
immune response after stimulation with sheep red cells. This loss of reactivity 
by the bone marrow from primed donors is specific for the antigen injected, 
since the immune response of the irradiated recipients to a non-cross-reacting 
antigen, the horse red blood cell, is unimpaired. Treatment of the bone marrow 
donors with high-titered specific antiserum to sheep red cells for 24 hr prior to 
sacrifice did not result in any diminished ability of their bone marrow cells to 
transfer antibody-forming capacity to sheep red blood cells. The significance of 
these results, with respect to the origin of the antigen-reactive and antibody- 
forming cells in the rabbit, is discussed. 
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